Aptose Biosciences Net Income From Continuing Ops Over Time
| APS Stock | CAD 2.26 0.01 0.44% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aptose Biosciences Performance and Aptose Biosciences Correlation. Aptose |
Cross Equities Net Income From Continuing Ops Analysis
Compare Aptose Biosciences and related stocks such as Kane Biotech, Avricore Health, and Appili Therapeutics Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KNE | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.6 M) | (1.7 M) | (2.5 M) | (2.8 M) | (3.3 M) | (960.2 K) | (3.8 M) | (4.8 M) | (3.8 M) | (4.5 M) | (3.2 M) | (2.8 M) | (3 M) |
| AVCR | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.6 M) | (2.7 M) | (4.1 M) | (1.9 M) | (1.2 M) | (1.7 M) | (818.2 K) | (701.2 K) | (669 K) | (769.3 K) | (807.8 K) |
| APLI | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4.3 M) | (5.4 M) | (14.3 M) | (25.1 M) | (9.2 M) | (3.8 M) | (2.6 M) | (2.4 M) | (2.5 M) |
| XRTX | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (629.6 K) | (1.3 M) | (1.7 M) | (7 M) | (2.2 M) | (3.3 M) | (3 M) | (3.1 M) |
| TELO | (401 K) | (401 K) | (401 K) | (401 K) | (401 K) | (1.8 M) | (9.9 M) | (4.7 M) | (1.1 M) | (1.2 M) | (1.1 M) | (2.1 M) | (2.8 M) | (2.7 M) | (2.7 M) | (3.1 M) | (3.3 M) |
| MUSH | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (1.6 M) | (452.1 K) | 40.6 K | (412.3 K) | (474.2 K) | (497.9 K) |
| CANB | (162.5 K) | (162.5 K) | (162.5 K) | (162.5 K) | (162.5 K) | (162.5 K) | (162.5 K) | (138.4 K) | (9 M) | (5.4 M) | (2.7 M) | 608 K | 4.4 M | (84.1 K) | (835.2 K) | (960.5 K) | (1 M) |
Aptose Biosciences and related stocks such as Kane Biotech, Avricore Health, and Appili Therapeutics Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Aptose Biosciences | APS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 66 Wellington Street |
| Exchange | Toronto Exchange |
CAD 2.26
Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.